250 related articles for article (PubMed ID: 17518432)
1. Structural basis for high-affinity peptide inhibition of human Pin1.
Zhang Y; Daum S; Wildemann D; Zhou XZ; Verdecia MA; Bowman ME; Lücke C; Hunter T; Lu KP; Fischer G; Noel JP
ACS Chem Biol; 2007 May; 2(5):320-8. PubMed ID: 17518432
[TBL] [Abstract][Full Text] [Related]
2. Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1.
Duncan KE; Dempsey BR; Killip LE; Adams J; Bailey ML; Lajoie GA; Litchfield DW; Brandl CJ; Shaw GS; Shilton BH
J Med Chem; 2011 Jun; 54(11):3854-65. PubMed ID: 21545152
[TBL] [Abstract][Full Text] [Related]
3. Substrate-based design of reversible Pin1 inhibitors.
Zhang Y; Füssel S; Reimer U; Schutkowski M; Fischer G
Biochemistry; 2002 Oct; 41(39):11868-77. PubMed ID: 12269831
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design of novel human Pin1 inhibitors (I).
Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
[TBL] [Abstract][Full Text] [Related]
5. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of novel human Pin1 inhibitors (II).
Dong L; Marakovits J; Hou X; Guo C; Greasley S; Dagostino E; Ferre R; Johnson MC; Kraynov E; Thomson J; Pathak V; Murray BW
Bioorg Med Chem Lett; 2010 Apr; 20(7):2210-4. PubMed ID: 20207139
[TBL] [Abstract][Full Text] [Related]
7. Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.
Liu T; Liu Y; Kao HY; Pei D
J Med Chem; 2010 Mar; 53(6):2494-501. PubMed ID: 20180533
[TBL] [Abstract][Full Text] [Related]
8. A reduced-amide inhibitor of Pin1 binds in a conformation resembling a twisted-amide transition state.
Xu GG; Zhang Y; Mercedes-Camacho AY; Etzkorn FA
Biochemistry; 2011 Nov; 50(44):9545-50. PubMed ID: 21980916
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1.
Daum S; Fanghänel J; Wildemann D; Schiene-Fischer C
Biochemistry; 2006 Oct; 45(39):12125-35. PubMed ID: 17002312
[TBL] [Abstract][Full Text] [Related]
10. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
[TBL] [Abstract][Full Text] [Related]
11. Stereospecific gating of functional motions in Pin1.
Namanja AT; Wang XJ; Xu B; Mercedes-Camacho AY; Wilson KA; Etzkorn FA; Peng JW
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12289-94. PubMed ID: 21746900
[TBL] [Abstract][Full Text] [Related]
12. Conformation-directed catalysis and coupled enzyme-substrate dynamics in Pin1 phosphorylation-dependent cis-trans isomerase.
Velazquez HA; Hamelberg D
J Phys Chem B; 2013 Oct; 117(39):11509-17. PubMed ID: 23980573
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.
Zhou XZ; Lu PJ; Wulf G; Lu KP
Cell Mol Life Sci; 1999 Nov; 56(9-10):788-806. PubMed ID: 11212339
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of novel human Pin1 inhibitors (III): optimizing affinity beyond the phosphate recognition pocket.
Guo C; Hou X; Dong L; Marakovits J; Greasley S; Dagostino E; Ferre R; Johnson MC; Humphries PS; Li H; Paderes GD; Piraino J; Kraynov E; Murray BW
Bioorg Med Chem Lett; 2014 Sep; 24(17):4187-91. PubMed ID: 25091930
[TBL] [Abstract][Full Text] [Related]
15. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
[TBL] [Abstract][Full Text] [Related]
16. Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1).
Liu L; Zhu R; Li J; Pei Y; Wang S; Xu P; Wang M; Wen Y; Zhang H; Du D; Ding H; Jiang H; Chen K; Zhou B; Yu L; Luo C
J Med Chem; 2022 Feb; 65(3):2174-2190. PubMed ID: 35089030
[TBL] [Abstract][Full Text] [Related]
17. Peptidyl prolyl isomerase Pin1-inhibitory activity of D-glutamic and D-aspartic acid derivatives bearing a cyclic aliphatic amine moiety.
Nakagawa H; Seike S; Sugimoto M; Ieda N; Kawaguchi M; Suzuki T; Miyata N
Bioorg Med Chem Lett; 2015 Dec; 25(23):5619-24. PubMed ID: 26508545
[TBL] [Abstract][Full Text] [Related]
18. Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.
Rostam MA; Piva TJ; Rezaei HB; Kamato D; Little PJ; Zheng W; Osman N
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):117-24. PubMed ID: 25377120
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into Pin1 peptidyl-prolyl cis-trans isomerization from umbrella sampling simulations.
Di Martino GP; Masetti M; Cavalli A; Recanatini M
Proteins; 2014 Nov; 82(11):2943-56. PubMed ID: 25066180
[TBL] [Abstract][Full Text] [Related]
20. A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.
Jiang B; Pei D
J Med Chem; 2015 Aug; 58(15):6306-12. PubMed ID: 26196061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]